{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:33:55Z","timestamp":1794980035948,"version":"4.9.1"},"reference-count":137,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leiden\u2013Edinburgh joint Ph.D. programme for Integrated One Health Solutions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Due to their ability to eliminate antimicrobial resistant (AMR) bacteria and to modulate the immune response, host defence peptides (HDPs) hold great promise for the clinical treatment of bacterial infections. Whereas monotherapy with HDPs is not likely to become an effective first-line treatment, combinations of such peptides with antibiotics can potentially provide a path to future therapies for AMR infections. Therefore, we critically reviewed the recent literature regarding the antibacterial activity of combinations of HDPs and antibiotics against AMR bacteria and the approaches taken in these studies. Of the 86 studies compiled, 56 featured a formal assessment of synergy between agents. Of the combinations assessed, synergistic and additive interactions between HDPs and antibiotics amounted to 84.9% of the records, while indifferent and antagonistic interactions accounted for 15.1%. Penicillin, aminoglycoside, fluoro\/quinolone, and glycopeptide antibiotic classes were the most frequently documented as interacting with HDPs, and Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Enterococcus faecium were the most reported bacterial species. Few studies formally evaluated the effects of combinations of HDPs and antibiotics on bacteria, and even fewer assessed such combinations against bacteria within biofilms, in animal models, or in advanced tissue infection models. Despite the biases of the current literature, the studies suggest that effective combinations of HDPs and antibiotics hold promise for the future treatment of infections caused by AMR bacteria.<\/jats:p>","DOI":"10.3390\/antibiotics12101518","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T14:03:03Z","timestamp":1696687383000},"page":"1518","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Complementary Activities of Host Defence Peptides and Antibiotics in Combating Antimicrobial Resistant Bacteria"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-0463","authenticated-orcid":false,"given":"Patrick R.","family":"Lennard","sequence":"first","affiliation":[{"name":"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK"},{"name":"Institute of Immunology and Infection, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FE, UK"},{"name":"PulmoScience Lab, Department of Pulmonology, Leiden University Medical Centre, Leiden 2333, The Netherlands"},{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden 2333, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-5982","authenticated-orcid":false,"given":"Pieter S.","family":"Hiemstra","sequence":"additional","affiliation":[{"name":"PulmoScience Lab, Department of Pulmonology, Leiden University Medical Centre, Leiden 2333, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Nibbering","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden 2333, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_2","unstructured":"O\u2019Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations, Wellcome Trust."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The Global Preclinical Antibacterial Pipeline","volume":"18","author":"Theuretzbacher","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug Repurposing for Antimicrobial Discovery","volume":"4","author":"Farha","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A Deep Learning Approach to Antibiotic Discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of Plasmid-Mediated Colistin Resistance Mechanism MCR-1 in Animals and Human Beings in China: A Microbiological and Molecular Biological Study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial Host Defence Peptides: Functions and Clinical Potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cbpa.2017.03.014","article-title":"Host Defense Antimicrobial Peptides as Antibiotics: Design and Application Strategies","volume":"38","author":"Mishra","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6968.1998.tb12896.x","article-title":"Mechanism of Antimicrobial Action of Indolicidin","volume":"160","author":"Subbalakshmi","year":"1998","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.chembiol.2014.10.009","article-title":"The Host Antimicrobial Peptide Bac71-35 Binds to Bacterial Ribosomal Proteins and Inhibits Protein Synthesis","volume":"21","author":"Mardirossian","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bin Hafeez, A., Jiang, X., Bergen, P.J., and Zhu, Y. (2021). Antimicrobial Peptides: An Update on Classifications and Databases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111691"},{"key":"ref_12","unstructured":"(2021, May 01). DRAMP Database. Available online: http:\/\/dramp.cpu-bioinfor.org\/browse\/ClinicalTrialsData.php."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#","article-title":"Evaluation of the Effects of Peptide Antibiotics Human \u03b2-Defensins-1\/-2 and LL-37 on Histamine Release and Prostaglandin D2 Production from Mast Cells","volume":"31","author":"Niyonsaba","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/eji.200636379","article-title":"Antimicrobial Peptides Human \u03b2-Defensin (hBD)-3 and hBD-4 Activate Mast Cells and Increase Skin Vascular Permeability","volume":"37","author":"Chen","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1399-302x.2000.150403.x","article-title":"Sensitivity of Actinobacillus Actinomycetemcomitans and Capnocytophaga spp. to the Bactericidal Action of LL-37: A Cathelicidin Found in Human Leukocytes and Epithelium","volume":"15","author":"Tanaka","year":"2000","journal-title":"Oral Microbiol. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2007.10.013","article-title":"Evaluation of the Inhibitory Effects of Human Serum Components on Bactericidal Activity of Human Beta Defensin 3","volume":"29","author":"Maisetta","year":"2008","journal-title":"Peptides"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1128\/AAC.48.12.4673-4679.2004","article-title":"Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus Aureus-Derived Proteinases","volume":"48","author":"Mydel","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated Proteolysis Regulates the Antimicrobial Effects of Cathelicidins in Skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.171.2.931","article-title":"Inactivation of Human \u03b2-Defensins 2 and 3 by Elastolytic Cathepsins","volume":"171","author":"Taggart","year":"2003","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"van Gent, M.E., Ali, M., Nibbering, P.H., and K\u0142odzi\u0144ska, S.N. (2021). Current Advances in Lipid and Polymeric Antimicrobial Peptide Delivery Systems and Coatings for the Prevention and Treatment of Bacterial Infections. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111840"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2300472","DOI":"10.1002\/advs.202300472","article-title":"Antimicrobial Peptide Synergies for Fighting Infectious Diseases","volume":"10","author":"Mhlongo","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acsinfecdis.2c00406","article-title":"Development of Antimicrobial Peptide\u2013Antibiotic Conjugates to Improve the Outer Membrane Permeability of Antibiotics against Gram-Negative Bacteria","volume":"8","author":"Yamauchi","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_23","first-page":"90","article-title":"Antibiotics: Classification and Mechanisms of Action with Emphasis on Molecular Perspectives","volume":"4","author":"Etebu","year":"2016","journal-title":"Int. J. Appl. Microbiol. Biotechnol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"a025288","DOI":"10.1101\/cshperspect.a025288","article-title":"Polymyxin: Alternative Mechanisms of Action and Resistance","volume":"6","author":"Trimble","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1021\/acs.jcim.3c00137","article-title":"Predicting Antimicrobial Activity for Untested Peptide-Based Drugs Using Collaborative Filtering and Link Prediction","volume":"63","author":"Medvedeva","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"ofaa302","DOI":"10.1093\/ofid\/ofaa302","article-title":"Antibiotics and Innate Immunity: A Cooperative Effort toward the Successful Treatment of Infections","volume":"7","author":"Berti","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/med.21879","article-title":"Antimicrobial Peptides, Conventional Antibiotics, and Their Synergistic Utility for the Treatment of Drug-Resistant Infections","volume":"42","author":"Zhu","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01121-14","article-title":"When Does 2 plus 2 Equal 5? A Review of Antimicrobial Synergy Testing","volume":"52","author":"Doern","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_29","unstructured":"Bogart, S. (2023, September 25). SankeyMATIC. A Sankey Diagram Builder for Everyone. Available online: http:\/\/sankeymatic.com."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.mie.2021.09.006","article-title":"Chapter One\u2014Unifying the Classification of Antimicrobial Peptides in the Antimicrobial Peptide Database","volume":"663","author":"Wang","year":"2022","journal-title":"Antimicrobial Peptides"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.70.1.1","article-title":"Studies on a Bactericidal Agent Extracted from a Soil Bacillus: I. Preparation of the Agent. Its Activity in Vitro","volume":"70","author":"Dubos","year":"1939","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.70.1.11","article-title":"Studies on a Bactericidal Agent Extracted from a Soil Bacillus: II. Protective Effect of the Bactericidal Agent against Experimental Pieuococcus Infections in Mice","volume":"70","author":"Dubos","year":"1939","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s00018-012-1202-3","article-title":"Anti-Infective Properties of Bacteriocins: An Update","volume":"70","author":"Hammami","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_34","first-page":"45","article-title":"Antimicrobial Peptide from Bacillus Subtilis CSB138: Characterization, Killing Kinetics, and Synergistic Potency","volume":"20","author":"Regmi","year":"2017","journal-title":"Int. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1099\/mic.0.000316","article-title":"Laterosporulin10: A Novel Defensin like Class IId Bacteriocin from Brevibacillus sp. Strain SKDU10 with Inhibitory Activity against Microbial Pathogens","volume":"162","author":"Baindara","year":"2016","journal-title":"Microbiology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/fmb-2016-0113","article-title":"Inhibition of MRSA and of Clostridium Difficile by Durancin 61A: Synergy with Bacteriocins and Antibiotics","volume":"12","author":"Hanchi","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_37","first-page":"3337","article-title":"Effects of the Antimicrobial Peptide L12 against Multidrug-resistant Staphylococcus Aureus","volume":"19","author":"Xiong","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jac\/dkf190","article-title":"Nisin, Alone and Combined with Peptidoglycan-Modulating Antibiotics: Activity against Methicillin-Resistant Staphylococcus Aureus and Vancomycin-Resistant Enterococci","volume":"50","author":"Brumfitt","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.resmic.2011.11.002","article-title":"Antibiotic and Antimicrobial Peptide Combinations: Synergistic Inhibition of Pseudomonas Fluorescens and Antibiotic-Resistant Variants","volume":"163","author":"Naghmouchi","year":"2012","journal-title":"Res. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Draper, L.A., Cotter, P.D., Hill, C., and Ross, R.P. (2013). The Two Peptide Lantibiotic Lacticin 3147 Acts Synergistically with Polymyxin to Inhibit Gram Negative Bacteria. BMC Microbiol., 13.","DOI":"10.1186\/1471-2180-13-212"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbrc.2004.07.008","article-title":"Antibiotic Activity and Synergistic Effect of Antimicrobial Peptide against Pathogens from a Patient with Gallstones","volume":"321","author":"Park","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/092986606774502018","article-title":"Antibiotic Activity of Antimicrobial Peptide against Pseudomonads Isolated from a Patient with Gallstones","volume":"13","author":"Park","year":"2006","journal-title":"Protein Pept. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.procbio.2013.01.008","article-title":"Design, Expression and Characterization of the Hybrid Antimicrobial Peptide LHP7, Connected by a Flexible Linker, against Staphylococcus and Streptococcus","volume":"48","author":"Xi","year":"2013","journal-title":"Process Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Deepa, I., Kumar, S.N., Sreerag, R.S., Nath, V.S., and Mohandas, C. (2015). Purification and Synergistic Antibacterial Activity of Arginine Derived Cyclic Dipeptides, from Achromobacter Sp. Associated with a Rhabditid Entomopathogenic Nematode against Major Clinically Relevant Biofilm Forming Wound Bacteria. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00876"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1128\/AAC.01245-15","article-title":"Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro","volume":"59","author":"Soren","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/mdr.2014.0221","article-title":"Antimicrobial Activity of Plectasin NZ2114 in Combination with Cell Wall Targeting Antibiotics against VanA-Type Enterococcus Faecalis","volume":"21","author":"Breidenstein","year":"2015","journal-title":"Microb. Drug Resist."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbt.2021.03.003","article-title":"Plant-Produced Bacteriocins Inhibit Plant Pathogens and Confer Disease Resistance in Tomato","volume":"63","author":"Mirzaee","year":"2021","journal-title":"New Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41467-023-37003-z","article-title":"Efficient in Planta Production of Amidated Antimicrobial Peptides That Are Active against Drug-Resistant ESKAPE Pathogens","volume":"14","author":"Chaudhary","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_49","first-page":"628","article-title":"Antibacterial Activity of the Recombinant Antimicrobial Peptide Ib-AMP4 from Impatiens Balsamina and Its Synergy with Other Antimicrobial Agents against Drug Resistant Bacteria","volume":"68","author":"Fan","year":"2013","journal-title":"Pharmazie"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Mohan, N.M., Zorgani, A., Jalowicki, G., Kerr, A., Khaldi, N., and Martins, M. (2019). Unlocking NuriPep 1653 From Common Pea Protein: A Potent Antimicrobial Peptide to Tackle a Pan-Drug Resistant Acinetobacter Baumannii. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02086"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.immunol.25.022106.141615","article-title":"The Host Defense of Drosophila Melanogaster","volume":"25","author":"Lemaitre","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e44341","DOI":"10.7554\/eLife.44341","article-title":"Synergy and Remarkable Specificity of Antimicrobial Peptides in Vivo Using a Systematic Knockout Approach","volume":"8","author":"Hanson","year":"2019","journal-title":"eLife"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.resmic.2012.06.001","article-title":"Synergistic Effect of Antimicrobial Peptide Arenicin-1 in Combination with Antibiotics against Pathogenic Bacteria","volume":"163","author":"Choi","year":"2012","journal-title":"Res. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10517-017-3708-z","article-title":"Analysis of Synergistic Effects of Antimicrobial Peptide Arenicin-1 and Conventional Antibiotics","volume":"162","author":"Bolosov","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/mdr.2018.0016","article-title":"Highly Synergistic Effects of Melittin with Conventional Antibiotics against Multidrug-Resistant Isolates of Acinetobacter Baumannii and Pseudomonas Aeruginosa","volume":"25","author":"Akbari","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2147\/IDR.S160975","article-title":"Novel Vancomycin\u2013Peptide Conjugate as Potent Antibacterial Agent against Vancomycin-Resistant Staphylococcus Aureus","volume":"11","author":"Jelinkova","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10989-016-9530-z","article-title":"In Vitro Synergistic Activities of the Hybrid Antimicrobial Peptide MelitAP-27 in Combination with Conventional Antibiotics against Planktonic and Biofilm Forming Bacteria","volume":"22","author":"Almaaytah","year":"2016","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/0929866522666150728115439","article-title":"In Vitro Synergistic Effect of the CM11 Antimicrobial Peptide in Combination with Common Antibiotics against Clinical Isolates of Six Species of Multidrug-Resistant Pathogenic Bacteria","volume":"22","author":"Amani","year":"2015","journal-title":"Protein Pept. Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4236\/aim.2018.87039","article-title":"Linear Thanatin Is an Effective Antimicrobial Peptide against Colistin-Resistant Escherichia coli in Vitro","volume":"8","author":"Zhou","year":"2018","journal-title":"Adv. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00284-012-0239-8","article-title":"Synergistic Effect and Antibiofilm Activity between the Antimicrobial Peptide Coprisin and Conventional Antibiotics against Opportunistic Bacteria","volume":"66","author":"Hwang","year":"2013","journal-title":"Curr. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Almaaytah, A., Farajallah, A., Abualhaijaa, A., and Al-Balas, Q. (2018). A3, A Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria. Molecules, 23.","DOI":"10.20944\/preprints201805.0356.v1"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Li, Z., Xu, X., Meng, L., Zhang, Q., Cao, L., Li, W., Wu, Y., and Cao, Z. (2014). Hp1404, a New Antimicrobial Peptide from the Scorpion Heterometrus Petersii. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097539"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Teerapo, K., Roytrakul, S., Sistayanarain, A., Kunthalert, D., and Id, D.K. (2019). A Scorpion Venom Peptide Derivative BmKn-22 with Potent Antibiofilm Activity against Pseudomonas aeruginosa. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218479"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.00686-17","article-title":"Synergistic Efficacy of Aedes Aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas Aeruginosa","volume":"61","author":"Zheng","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.5012\/bkcs.2009.30.8.1839","article-title":"Antibacterial Activity and Synergism of the Hybrid Antimicrobial Peptide, CAMA-Syn","volume":"30","author":"Jeong","year":"2009","journal-title":"Bull. Korean Chem. Soc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"111636","DOI":"10.1016\/j.ejmech.2019.111636","article-title":"Design and Synthesis of New N-Terminal Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent in Vitro Biological Activity","volume":"182","author":"Zhong","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.peptides.2016.12.016","article-title":"Design of Novel Antimicrobial Peptide Dimer Analogues with Enhanced Antimicrobial Activity in Vitro and in Vivo by Intermolecular Triazole Bridge Strategy","volume":"88","author":"Liu","year":"2017","journal-title":"Peptides"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105453","DOI":"10.1016\/j.ejps.2020.105453","article-title":"Effect of N-Methylated and Fatty Acid Conjugation on Analogs of Antimicrobial Peptide Anoplin","volume":"152","author":"Liu","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s12272-015-0565-z","article-title":"ZL-2, a Cathelicidin-Derived Antimicrobial Peptide, Has a Broad Antimicrobial Activity against Gram-Positive Bacteria and Gram-Negative Bacteria in Vitro and in Vivo","volume":"38","author":"Tu","year":"2015","journal-title":"Arch. Pharmacal. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/s41598-019-40103-w","article-title":"Transportan 10 Improves the Pharmacokinetics and Pharmacodynamics of Vancomycin","volume":"9","author":"Rusiecka","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1128\/AAC.01576-06","article-title":"Efficacy of Tachyplesin III, Colistin, and Imipenem against a Multiresistant Pseudomonas Aeruginosa Strain","volume":"51","author":"Cirioni","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.bbagen.2012.08.012","article-title":"Antimicrobial Peptide Pleurocidin Synergizes with Antibiotics through Hydroxyl Radical Formation and Membrane Damage, and Exerts Antibiofilm Activity","volume":"1820","author":"Choi","year":"2012","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Chen, Y., Wu, J., Cheng, H., Dai, Y., Wang, Y., Yang, H., Xiong, F., Xu, W., and Wei, L. (2020). Anti-Infective Effects of a Fish-Derived Antimicrobial Peptide against Drug-Resistant Bacteria and Its Synergistic Effects With Antibiotic. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.602412"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijantimicag.2010.01.016","article-title":"In Vivo Efficacy of the Antimicrobial Peptide Ranalexin in Combination with the Endopeptidase Lysostaphin against Wound and Systemic Meticillin-Resistant Staphylococcus Aureus (MRSA) Infections","volume":"35","author":"Desbois","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/jac\/dkt243","article-title":"MRSA Decolonization of Cotton Rat Nares by a Combination Treatment Comprising Lysostaphin and the Antimicrobial Peptide Ranalexin","volume":"68","author":"Desbois","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00284-014-0529-4","article-title":"In Vitro Synergistic Activities of Antimicrobial Peptide Brevinin-2CE with Five Kinds of Antibiotics against Multidrug-Resistant Clinical Isolates","volume":"68","author":"Zhang","year":"2014","journal-title":"Curr. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Casciaro, B., Loffredo, M.R., Cappiello, F., Fabiano, G., Torrini, L., and Mangoni, M.L. (2020). The Antimicrobial Peptide Temporin G: Anti-Biofilm, Anti-Persister Activities, and Potentiator Effect of Tobramycin Efficacy against Staphylococcus Aureus. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249410"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Arnusch, C.J., Pieters, R.J., and Breukink, E. (2012). Enhanced Membrane Pore Formation through High-Affinity Targeted Antimicrobial Peptides. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039768"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.00095-14","article-title":"Therapeutic Potential of the Antimicrobial Peptide Oh-Cath30 for Antibiotic-Resistant Pseudomonas Aeruginosa Keratitis","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.2174\/0929867325666180713125314","article-title":"Antimicrobial Peptides: Amphibian Host Defense Peptides","volume":"26","author":"Patocka","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3389\/fphar.2019.01415","article-title":"Snake Venom Cathelicidins as Natural Antimicrobial Peptides","volume":"10","author":"Cardoso","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/icb.2009.19","article-title":"Differing Effects of Exogenous or Endogenous Cathelicidin on Macrophage Toll-like Receptor Signaling","volume":"87","author":"Gallo","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.peptides.2005.09.016","article-title":"Development of Novel LL-37 Derived Antimicrobial Peptides with LPS and LTA Neutralizing and Antimicrobial Activities for Therapeutic Application","volume":"27","author":"Nell","year":"2006","journal-title":"Peptides"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","article-title":"Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens","volume":"2","author":"Lin","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/AAC.02481-12","article-title":"Treatment of High-Level Gentamicin-Resistant Enterococcus Faecalis Endocarditis with Daptomycin plus Ceftaroline","volume":"57","author":"Sakoulas","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin plus Ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin. Ther."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1128\/AAC.00053-15","article-title":"\u03b2-Lactams Enhance Daptomycin Activity against Vancomycin-Resistant Enterococcus Faecalis and Enterococcus Faecium in in Vitro Pharmacokinetic\/Pharmacodynamic Models","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41429-018-0090-7","article-title":"Evaluation of LL-37 Antimicrobial Peptide Derivatives Alone and in Combination with Vancomycin against S. Aureus","volume":"71","author":"Shurko","year":"2018","journal-title":"J. Antibiot."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","article-title":"Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus Faecium","volume":"56","author":"Sakoulas","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijantimicag.2017.04.014","article-title":"Activity of Innate Antimicrobial Peptides and Ivacaftor against Clinical Cystic Fibrosis Respiratory Pathogens","volume":"50","author":"Payne","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Ruden, S., Rieder, A., Chis Ster, I., Schwartz, T., Mikut, R., and Hilpert, K. (2019). Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas Aeruginosa. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02740"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e00410-17","DOI":"10.1128\/mSphere.00410-17","article-title":"Interaction of Antibiotics with Innate Host Defense Factors against Salmonella Enterica Serotype Newport","volume":"2","author":"Sakoulas","year":"2017","journal-title":"mSphere"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Zharkova, M.S., Orlov, D.S., Golubeva, O.Y., Chakchir, O.B., Eliseev, I.E., Grinchuk, T.M., and Shamova, O.V. (2019). Application of Antimicrobial Peptides of the Innate Immune System in Combination with Conventional Antibiotics\u2014A Novel Way to Combat Antibiotic Resistance?. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00128"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"13121","DOI":"10.1038\/s41598-020-69962-4","article-title":"Human Antimicrobial Peptide, LL-37, Induces Non-Inheritable Reduced Susceptibility to Vancomycin in Staphylococcus aureus","volume":"10","author":"Friberg","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","article-title":"Nafcillin Enhances Innate Immune-Mediated Killing of Methicillin-Resistant Staphylococcus Aureus","volume":"92","author":"Sakoulas","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ridyard, K.E., Elsawy, M., Mattrasingh, D., Klein, D., Strehmel, J., Beaulieu, C., Wong, A., and Overhage, J. (2023). Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020389"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbamem.2017.01.037","article-title":"LL-37-Derived Membrane-Active FK-13 Analogs Possessing Cell Selectivity, Anti-Biofilm Activity and Synergy with Chloramphenicol and Anti-Inflammatory Activity","volume":"1859","author":"Rajasekaran","year":"2017","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejmech.2017.05.028","article-title":"LL-37-Derived Short Antimicrobial Peptide KR-12-A5 and Its D-Amino Acid Substituted Analogs with Cell Selectivity, Anti-Biofilm Activity, Synergistic Effect with Conventional Antibiotics, and Anti-Inflammatory Activity","volume":"136","author":"Kim","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2018.10.002","article-title":"Synergistic Microbicidal Effect of Cationic Antimicrobial Peptides and Teicoplanin against Planktonic and Biofilm-Encased Staphylococcus Aureus","volume":"53","author":"Koppen","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/bkcs.11381","article-title":"Fowlicidin-3 Analog with Improved Cell Selectivity Synthesized by Shifting a PXXP Motif from the N-Terminus to a Central Position","volume":"39","author":"Rajasekaran","year":"2018","journal-title":"Bull. Korean Chem. Soc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbamem.2018.06.016","article-title":"Antimicrobial and Anti-Inflammatory Activities of Chemokine CXCL14-Derived Antimicrobial Peptide and Its Analogs","volume":"1861","author":"Rajasekaran","year":"2019","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"van Gent, M.E., van der Reijden, T.J.K., Lennard, P.R., de Visser, A.W., Schonkeren-Ravensbergen, B., Dolezal, N., Cordfunke, R.A., Drijfhout, J.W., and Nibbering, P.H. (2022). Synergism between the Synthetic Antibacterial and Antibiofilm Peptide (SAAP)-148 and Halicin. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050673"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Mohammed, I., Said, D.G., Nubile, M., Mastropasqua, L., and Dua, H.S. (2019). Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas Aeruginosa. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02190"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1039\/C5OB00830A","article-title":"Evaluation of the Antibacterial and Antibiofilm Activities of Novel CRAMP-Vancomycin Conjugates with Diverse Linkers","volume":"13","author":"Mishra","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/AAC.03163-14","article-title":"A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms","volume":"58","author":"Reffuveille","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/DDDT.S107195","article-title":"Synergistic Effects of Antimicrobial Peptide DP7 Combined with Antibiotics against Multidrug-Resistant Bacteria","volume":"11","author":"Wu","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2009.05.003","article-title":"Antimicrobial and Antifungal Activities of a Novel Cationic Antimicrobial Peptide, Omiganan, in Experimental Skin Colonisation Models","volume":"34","author":"Rubinchik","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2567.2002.01430.x","article-title":"Expression of \u03b2-Defensin 1 and 2 mRNA by Human Monocytes, Macrophages and Dendritic Cells","volume":"106","author":"Duits","year":"2002","journal-title":"Immunology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e10455","DOI":"10.7717\/peerj.10455","article-title":"Antibacterial Activity of Human Defensins against Staphylococcus aureus and Escherichia coli","volume":"8","author":"Bolatchiev","year":"2020","journal-title":"PeerJ"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2011.02.015","article-title":"A Recombinant Antimicrobial Peptide Inhibits the Growth of Oxacillin-Induced l-Forms of Staphylococcus aureus","volume":"38","author":"Wang","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/acsinfecdis.2c00280","article-title":"Efficacy and Toxicity Studies of Novel \u03b1-MSH Analogues with Antibiofilm Action and \u03b2-Lactam Resensitization Potential against MRSA","volume":"8","author":"Mumtaz","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.biomaterials.2015.02.105","article-title":"Versatile Antimicrobial Peptide-Based ZnO Quantum Dots for Invivo Bacteria Diagnosis and Treatment with High Specificity","volume":"53","author":"Chen","year":"2015","journal-title":"Biomaterials"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1039\/C5MD00392J","article-title":"Antimicrobial Activity of Levofloxacin-M33 Peptide Conjugation or Combination","volume":"7","author":"Ceccherini","year":"2016","journal-title":"MedChemComm"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/psc.2978","article-title":"Synergistic Activity Profile of an Antimicrobial Peptide against Multidrug-Resistant and Extensively Drug-Resistant Strains of Gram-Negative Bacterial Pathogens","volume":"23","author":"Pollini","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Almaaytah, A., Qaoud, M.T., Mohammed, G.K., Abualhaijaa, A., Knappe, D., Hoffmann, R., and Al-Balas, Q. (2018). Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine. Pharmaceuticals, 11.","DOI":"10.3390\/ph11010003"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.biomaterials.2013.11.035","article-title":"Anti-Mycobacterial Activities of Synthetic Cationic \u03b1-Helical Peptides and Their Synergism with Rifampicin","volume":"35","author":"Khara","year":"2014","journal-title":"Biomaterials"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1021\/acsmedchemlett.7b00200","article-title":"Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA","volume":"8","author":"Lainson","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"25905","DOI":"10.1038\/srep25905","article-title":"Branched Peptide, B2088, Disrupts the Supramolecular Organization of Lipopolysaccharides and Sensitizes the Gram-Negative Bacteria","volume":"6","author":"Lakshminarayanan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fchem.2018.00309","article-title":"Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in Vitro and in Vivo","volume":"6","author":"Otvos","year":"2018","journal-title":"Front. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2147\/IDR.S215084","article-title":"Synergism of Cationic Antimicrobial Peptide WLBU2 with Antibacterial Agents against Biofilms of Multi-Drug Resistant Acinetobacter Baumannii and Klebsiella Pneumoniae","volume":"12","author":"Swedan","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0196-9781(01)00498-3","article-title":"From \u201cCarpet\u201d Mechanism to de-Novo Designed Diastereomeric Cell-Selective Antimicrobial Peptides","volume":"22","author":"Shai","year":"2001","journal-title":"Peptides"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chembiol.2015.01.002","article-title":"D-Enantiomeric Peptides That Eradicate Wild-Type and Multidrug-Resistant Biofilms and Protect against Lethal Pseudomonas Aeruginosa Infections","volume":"22","author":"Reffuveille","year":"2015","journal-title":"Chem. Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1128\/AAC.00092-15","article-title":"Antibiofilm Peptides Increase the Susceptibility of Carbapenemase-Producing Klebsiella Pneumoniae Clinical Isolates to \u03b2-Lactam Antibiotics","volume":"59","author":"Ribeiro","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1038\/s41598-017-07440-0","article-title":"A Short D-Enantiomeric Antimicrobial Peptide with Potent Immunomodulatory and Antibiofilm Activity against Multidrug-Resistant Pseudomonas Aeruginosa and Acinetobacter Baumannii","volume":"7","author":"Mohamed","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Baker, K.R., Jana, B., Hansen, A.M., Nielsen, H.M., Franzyk, H., and Guardabassi, L. (2019). Repurposing Azithromycin and Rifampicin against Gram-Negative Pathogens by Combination with Peptidomimetics. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00236"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1039\/C9MD00051H","article-title":"Polybasic Peptide-Levofloxacin Conjugates Potentiate Fluoroquinolones and Other Classes of Antibiotics against Multidrug-Resistant Gram-Negative Bacteria","volume":"10","author":"Berry","year":"2019","journal-title":"MedChemComm"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.carres.2011.01.015","article-title":"Synthesis and Antibacterial Activity of Amphiphilic Lysine-Ligated Neomycin B Conjugates","volume":"346","author":"Bera","year":"2011","journal-title":"Carbohydr. Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bbamem.2019.05.008","article-title":"Synergistic and Antibiofilm Activity of the Antimicrobial Peptide P5 against Carbapenem-Resistant Pseudomonas aeruginosa","volume":"1861","author":"Martinez","year":"2019","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbagen.2017.01.029","article-title":"Targeting Biofilms and Persisters of ESKAPE Pathogens with P14KanS, a Kanamycin Peptide Conjugate","volume":"1861","author":"Mohamed","year":"2017","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.12.032","article-title":"A Review of Lipidation in the Development of Advanced Protein and Peptide Therapeutics","volume":"295","author":"Decker","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/C5MD00373C","article-title":"Synergistic Activity of a Short Lipidated Antimicrobial Peptide (lipoAMP) and Colistin or Tobramycin against Pseudomonas aeruginosa from Cystic Fibrosis Patients","volume":"7","author":"Josten","year":"2016","journal-title":"MedChemComm"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1126\/science.1260580","article-title":"Antimicrobial Peptide Resistance Mediates Resilience of Prominent Gut Commensals during Inflammation","volume":"347","author":"Cullen","year":"2015","journal-title":"Science"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"958480","DOI":"10.3389\/froh.2022.958480","article-title":"Antimicrobial Peptides: Defending the Mucosal Epithelial Barrier","volume":"3","author":"Johnstone","year":"2022","journal-title":"Front. Oral Health"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e24290","DOI":"10.1002\/pep2.24290","article-title":"Advances in the Use of Plants as Potential Biofactories in the Production of Antimicrobial Peptides","volume":"115","author":"Franco","year":"2023","journal-title":"Pept. Sci."},{"key":"ref_135","unstructured":"Yoder, W., and Lehmbeck, J. (2004). Advances in Fungal Biotechnology for Industry, Agriculture, and Medicine, Springer."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/mic.0.27116-0","article-title":"Drosophila Melanogaster as a Model Host for Staphylococcus Aureus Infection","volume":"150","author":"Needham","year":"2004","journal-title":"Microbiology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nprot.2009.124","article-title":"Drosophila Melanogaster as a Model Host for Studying Pseudomonas Aeruginosa Infection","volume":"4","author":"Apidianakis","year":"2009","journal-title":"Nat. Protoc."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/10\/1518\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:02:14Z","timestamp":1760130134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/10\/1518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":137,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["antibiotics12101518"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12101518","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]}}}